Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 358 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.956,7-dihydropteridine reductase deficiency 15581159 Cerebral folate deficiency. causal interaction
unassigned
4
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma 25719555 Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
4
4
4
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma 28614715 PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis. causal interaction
diagnostic usage
therapeutic application
unassigned
3
4
1
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma 30744688 Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
4
4
1
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma 30852233 Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase. causal interaction
therapeutic application
unassigned
1
4
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma 34295659 One carbon metabolism in human lung cancer. diagnostic usage
ongoing research
therapeutic application
unassigned
3
3
1
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma of Lung 28614715 PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis. causal interaction
diagnostic usage
therapeutic application
unassigned
3
4
1
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma of Lung 29556358 Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase. causal interaction
therapeutic application
unassigned
1
4
0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenocarcinoma of Lung 33664874 Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum. unassigned 0
Show all pathways known for 1.1.1.95Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.95Adenoma 34518477 Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms. causal interaction
diagnostic usage
ongoing research
unassigned
3
2
2
0
Results 1 - 10 of 358 > >>